Twenty-four cardiopulmonary bypass (CPB) per fusion units around Australia were surveyed to determine the characteristics of CPB per fusion as practised in Australia in 1992. Twenty completed survey forms were received. Findings were compared with those of a similar study performed by one of the authors for the year 1986. The field of CPB per fusion continues to expand both in terms of numbers of cases and increasing technological complexity. The major technological changes evident are the now clear dominance of membrane over bubble oxygenators and the proliferation of inline S V 02 monitoring devices. The greatest change in practice has been to the virtually universal use of cardioplegia. There remains considerable variation in the composition of the cardioplegia solutions used in the responding units. A range of minimum per fusion pressures for CPB is noted, whereas most units employ similar minimum per fusion flows. Methods of central nervous system and renal protection are mainly hypothermia and diuretics, respectively, with a scattering of other techniques. Staffing of CPB per fusion units is essentially unchanged since 1986 and at least five units had no medical per fusionist appointed in 1992.
spread in Australia and as the population ages, surgery is used more frequently for symptomatic control of coronary artery disease and the number of patients presenting for re-operation increases. CPB perfusion is utilised for virtually every case. Several new units providing cardiac surgical and perfusion services are scheduled to open or have recently done so. In Australia a significant proportion of all perfusion is conducted or directly supervised by medically trained perfusionists (unlike some countries, notably the USA). The majority of these medical perfusionists have specialist anaesthetist qualifications. We felt that documentation of the characteristics of CPB per fusion as practised in Australia in the last twelve months would be of interest to practitioners in the field and provide useful and timely information from which to plan future manpower and research directions. Such a survey would also update and allow comparison with similar data collected by one of us (RGW) in 1987. I
MATERIALS AND METHODS
A 33-question survey form was circulated to the 24 CPB perfusion units in Australia at the beginning of August 1992. The form was sent to the person (medical or non-medical) identified as primarily responsible for per fusion activities in each unit. The survey examined the numbers and types of cases done in 1991 (the last full year for which statistics were available), and the equipment, techniques, drugs used and personnel involved in provision of perfusion services at the time of the survey. Some questions required simple numeric answers. The remainder were multiple-choice with space for percentage answers, attempting to account for the variation in practices between individual perfusionists within units. Respondents were asked to supply accurate estimates if the requested information was not on a database. Twenty units returned completed forms and one unit declined to participate due to concerns about confidentiality. Further efforts made to contact non-responders were limited to one reminder letter and one telephone contact. The data were interpreted as given and no clarification of answers or sources was requested. The 1987 survey was less comprehensive than the current one and limited, qualified comparisons were made in those areas covered by both surveys. Eighteen of twenty units returned completed There is little change since 1986 in the types of cases being done, with coronary artery bypass graft (CABG) surgery accounting for 73UJo (cf. 70UJo in 1986), valvular surgery some 11% (cf. 13UJo), and combined procedures some 5UJo. Paediatric cases accounted for 7UJo, and transplants and other procedures for about 3UJo.
RESULTS

Numbers and 7j;pes of Cases
Estimated average bypass times for selected procedures were also surveyed for interest. Times ranged from 50 to 130 (mean 77) minutes for 3-4 coronary anastomoses, including internal mammary artery graft, and from 45 to 101 (mean 52) minutes for a mitral valve replacement. 
Pump, Oxygenator and Circuit Equipment
Increasing preference for membrane devices has resulted in bubble oxygenator usage falling from 55UJo of all perfusion cases in 1986 to 13% in 1992 (estimated, Figure 2 ). Bentley products (Baxter Healthcare Pty Ltd) are the most commonly used bubble oxygenators and are the choice of the one large unit which uses only this type. Two other units use bubble oxygenators for selected cases. Eleven units used more than one brand or type of oxygenator. Oxygenator usage by model is shown in Figure 3 and manufacturers listed in appendix 2. Most units follow a routine bypass perfusion circuit set-up, with only six units varying the circuit components at all. The roller pump reigns supreme, with only four units using a centrifugal pump for a very small percentage of CPB cases (some units did indicate experience with the latter for ventricular assist device (VAD) or extra-corporeal membrane oxygenation (ECMO) applications). There remains no agreement as to the efficacy of additional circuit filters (arterial line or pre-bypass) or C02 flushing as these measures have far from universal application and in fact are even slightly less utilised than in 1986 ( Table 2 ). A variety of drugs are added to the priming solution before bypass, the only universal one being heparin. Five or less of the responding units added diuretics, bicarbonate, muscle relaxants, potassium, calcium, intravenous anaesthetic agents or vasodilators at least 20070 of the time. Only one unit ever adds steroids and one other adds aprotonin (Trasylol@).
The use of monitoring devices was an all-or-none phenomenon within units. Several monitors (activated clotting time (ACT) determinations, arterial blood gases, low reservoir volume, arterial line pressure, arterial and central venous pressures) are used universally, although one unit stated it did not measure ACT prior to CPB. Six units did not use any kind of bubble detector. The use of in-line oximetry has become reasonably widespread, with 15 of the 20 responding units routinely monitoring the mixed venous oxygen saturation (SV02) in the venous line of the circuit.
Perfusion Practices
Minimum body core temperatures achieved during CPB perfusion remain comparable with practices in 1986 ( Table 3 ). The 1992 data suggest most units cool to a lower core temperature for longer and more complex procedures. Only two units routinely stay at or just above 30 QC and none reported practising warm heart surgery during CPB.
Preferred arterial blood gas management during CPB remains variable. Eighteen units use Alpha-stat values for pH and pe02 (see discussion). Most units aim for CPB P02 between lOO and 300 mmHg but four units prefer the P0 2 above 300, while one unit accepts a value anywhere between lOO and 600. Drug additions during bypass were similar in scope to pre-bypass and no addition was universal. The most frequently added drugs, used by half of the 20 responding units, were anaesthetic agents and vasoactive agents.
The use of cardioplegia is now almost universal for myocardial protection, compared with 1986 when 33% of units did not use cardioplegia for every case. In 1992 only one unit reported the non-use of cardioplegia in approximately 40% of its cases. Blood-containing cardioplegia solutions are now used in 12 units more than 20% of the time, and most of these use it for all cases. There has been a corresponding reduction in the use of crystalloid solutions. There is less use of an initial dose of crystalloid cardioplegia followed by subsequent doses of blood cardioplegia. The anterograde route is the most common (greater than 80% of administrations) but 11 units use retrograde administration in some cases. Administration of cardioplegia by the perfusionist is more common than in 1986 and is probably due to the increased use of /lf1(1(!Slilnia and In/cl/sil'e Care, ~"()1. 21, So, 6, Decemher, 1993 blood cardioplegia. Eighteen of the 20 units use some form of topical cold surface irrigation to assist myocardial protection.
There remain wide differences in opinion with respect to optimal minimum perfusion pressures during CPB. Approximately equal numbers of units maintain pressures below 40, between 40 and 60 or above 60 mmHg during normothermia or hypothermia. Fewer units keep the pressure above 60 in 1992 than in 1986 (Thble 4). Better consensus exists for optimal minimum flows on CPB, with the majority of units utilising 2.2-2.4l!min.lm 2 at normothermia and down to 66070 of this at hypothermia ( Table 5 ). Many of the units that used lower flows, especially during hypothermia, used the SV02 as their indicator of adequate flow. Only three units used pulsatile flows for some cases, and only one of these used this with any regularity (20% of cases). Protection of the at-risk kidney during CPB procedures remains controversial, as evidenced by the scattering of methods employed. Diuretics are most frequently used (13 units), followed by ultrafiltration (eight units) and dopamine infusion (seven units). Preoperative hydration and haemodialysis on bypass were each used by three units for at-risk patients. Only one of the responding units used pulsatile flow and in one other high perfusion pressures were used.
Per fusion Unit Staffing
The survey also reviewed the staffing situation of units providing CPB perfusion services. In 13 units responsibility for perfusion was held by medical perfusionists (defined as a medical practitioner who is neither operating nor anaesthetising during the case), which is similar to the situation in 1986. There has been a slight reduction in cases performed by autonomous non-medical (clinical) perfusionists and a slight increase in perfusions supervised by the anaesthetist and/or surgeon. Five of the responding units had no medical perfusionist appointed.
In terms of actual involvement, medical perfusionists directly operate the pump in 29% of all perfusions, dire<;tly and proximately supervise clinical perfusionists in a further 45% of cases and remotely supervise in only 5% of cases (Table 6 ). These figures would suggest that medical per fusionists spend more time in the operating theatre than they did in 1986. Overall, medical perfusionists are involved to some degree in about 80% of cases, a situation similar to 1986. Little has changed in medical perfusionist qualifications, with specialist anaesthetists making up the vast majority (89% cf. 85% in 1986). Among clinical perfusionists, technical college qualifications alone are now infrequent and the number of personnel holding the Certified Clinical Perfusionist (CCP, Australasia) qualification has equalled the number with a science degree.
Other
A significant number of the responding units conducted activities apart from clinical perfusion. 
DISCUSSION
Completed survey forms from 20 of the 24 CPB perfusion units in Australia at October 1992 provided sufficiently representative data to fulfil the aims of the survey. The case number data from the responding units correlate with the National Heart Foundation statistics. Most returns contained detail and comments beyond those required, suggesting interest in the project and adding credence to the data estimates requested. We did not expect the respondents to have all the required information on a database and have presented the results considering the limitations of the survey technique. Apart from the survey conducted by one of us (RGW) in 1986, and presented orally, we could find no similar, comprehensive reports in the literature.
The numerical census data confirm that the field of CPB per fusion continues to expand, not only in terms of numbers of units and total cases, but also in caseload per unit. The increased workload is not as marked in paediatrics, although one (smaller) paediatric unit did not respond to the survey. The composition of the caseload has not changed since 1986 in most units.
A significant decline in usage of bubble oxygenators (BO), with a corresponding increase in membrane devices since 1986, has resulted in the clear dominance of the latter in 1992. Price and performance for specific applications were the major selection criteria of the respondents in this survey. Recent review articles '.' have discussed the reasons for this shift in oxygenator technology. Membrane oxygenator (MO) use is associated with less complement activation, less platelet destruction and dysfunction, less gaseous microemboli production, lower risk of air embolism and superior blood gas control (including alpha-stat acid-base management). However, no studies have shown any measurable benefit in the late postoperative period with the use of the MO. Modern MOs are as easy to prime and use as BOs and the only advantages the BO has today are lower cost and probable parity in clinical outcome for perfusions of less than two hours' duration.
The other major technological change now evident is the proliferation of inline SV02 monitoring devices.
While these have theoretical appeal, and provide reassurance about adequacy of oxygenation and flows during bypass, the devices have not been in use long enough to be shown effective in large studies.
Alpha-stat management of arterial blood pH during hypothermic bypass is the preferred option in most of the responding units, although there are no large outcome studies to favour this approach. The use of such "temperature-uncorrected" values is generally thought to best preserve matching of cerebral metabolism to blood flow. pH-stat management (by adding C02 to the ventilating gas) may uncouple metabolism and flow, leading to excessive perfusion and raised intracranial pressure.
There is a trend towards increased use of mixed crystalloidlcolloid priming solutions in adult patients (the 1986 data did not address this aspect fully and no true comparison can be made). This perhaps reflects the increased number of patients with poor left ventricular function or longer CPB times associated with more grafts per case. There remains debate regarding the benefit(s) of routinely adding colloids to the pump prime. 4 The major change in clinical practice has been towards the universal use of cardioplegia. The use of blood-containing cardioplegia solutions and the retrograde administration route has increased. However, the variety of responses suggests it remains unclear as to what are the optimal composition and delivery regimes of cardioplegia solutions. It is likely that different clinical situations require variable combinations of solutions and deliveries. 5 While there is reasonable agreement among the responding units on adequate minimum perfusion flows, there has been no resolution of the issue of optimal perfusion pressures for CPB. Studies assessing perfusion/flow regimes, and particularly resultant neurological sequelae, are confounded by the impact of haemodilution, hypothermia and acid-base management, as well as the difficulty of detecting more subtle CNS dysfunction post-CPB. 6 Arguments emphasising the greater importance of pressure are generally weak. Adequacy of flows may be monitored with continuous SV02 as the majority of responding units now measure routinely. The evidence would indicate that there is no definite prescribed flow rate, but a range of physiological parameters within which one can perfuse with a relative margin of safety depending on the prevailing circumstances.
Recent attention in the medical literature, including the Royal Australasian College of Surgeons (RACS) Policy Statement "Autologous Blood Transfusion in Elective Surgery", may increase the use of pre-donated autologous blood in suitable cardiac surgical patients. 7 The situation of staffing of CPB perfusion units has not really changed since 1986 and at least five units have no medical perfusionist appointed in 1992. This is despite statements on management of CPB issued in 1986 by the Faculty of Anaesthetists, RACS and again in 1991 jointly with the Section of Cardio-Thoracic Surgery, RACS. 8 In conclusion, the survey has summarised the current state of CPB perfusion as practised in Australia. Many aspects of practice deserve further investigation, preferably utilising outcome studies. The high rate of medical perfusionist involvement in Australia provides a unique opportunity to conduct appropriate studies needed to refine equipment and techniques. A repeat survey in the future will be required to assess changes in the field.
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Please comment on your indications for use of each type of pump head. 
